The global sterility indicators market size was USD 1.10 billion in 2023, calculated at USD 1.24 billion in 2024 and is expected to be worth around USD 4.02 billion by 2034. The market is slated to expand at 12.51% CAGR from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Sterility Indicators Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Sterility Indicators Market Revenue and Volume, by Type, 2024-2034
8.1.1 Chemical
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Biological
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Sterility Indicators Market Revenue and Volume, by Technique, 2024-2034
9.1.1. Heat
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Low Temperature
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Filtration
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Radiation
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Liquid
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Sterility Indicators Market Revenue and Volume, by End-user, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Pharmaceutical Companies
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Medical Device Companies
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Clinical Laboratories/Research Centers
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Technique (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
12.1. Getinge Group
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cantel Medical Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. 3M Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cardinal Health, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Matachana Group
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Mesa Laboratories, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Andersen Products, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample